Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Livongo Health Inc. LVGO

Livongo Health Inc provides a data science and technology enabled platform for detection of diabetes. Its additional solutions include Livongo for Hypertension, Livongo for Prediabetes and Weight Management, and Livongo for Behavioral Health by myStrength. The company's client comprise of employers, health plans, government entities, and labor unions. Its operations are primarily located in the United States.


NDAQ:LVGO - Post by User

Post by laurencelefouon Aug 05, 2020 3:39pm
174 Views
Post# 31368732

Unbelievable

Unbelievable
  • Teladoc is offering $18,500,000,000 to buy Livongo.  Livongo has annual revenue of ±$640,000,000, that is 29 times revenue.  For the quarter ending June 30, 2020, Livongo lost $1,554,000.  For the six month period ending June 30, 2020, cash flows from operating activities were also negative at -$3,600,000.  An investor wanting a return on capital ($18,500,000,000) of at least 3% would expect to receive annually $550,000,000.  How many years will it take for Livongo to generate $550,000,000 in annual profits?

<< Previous
Bullboard Posts
Next >>